Oncology - Side Effects News & Articles

1 Can procalcitonin distinguish infectious fever from tumor-related fever in non-neutropenic cancer patients Cancer, May 23, 2012

2 Comparative effectiveness of filgrastim, pegfilgrastim, and sargramostim as prophylaxis against hospitalization for neutropenic complications in patients with cancer receiving chemotherapy American Journal of Clinical Oncology, May 23, 2012

3 Is There a Clinical Benefit to Adaptive Planning During Tomotherapy in Patients with Head and Neck Cancer at Risk for Xerostomia American Journal of Clinical Oncology, May 22, 2012

4 Electroclinical biomarkers of early peripheral neurotoxicity from oxaliplatin European Journal of Cancer Care, May 22, 2012    Clinical Article

5 Investigation of bendamustine HCL in a Phase 2 study in women with resistant ovarian cancer Full Text Investigational New Drugs, May 18, 2012    Clinical Article

6 Oxaliplatin-related thrombocytopenia Annals of Oncology, May 14, 2012    Clinical Article
Exclusive Author Commentary

7 Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil/epirubicin/cyclophosphamide (FEC) and docetaxel: a prospective study of 20 patients Annals of Oncology, May 11, 2012    Clinical Article

8 An SNP in CYP39A1 is associated with severe neutropenia induced by docetaxel Cancer Chemotherapy and Pharmacology, May 11, 2012

9 POEMS syndrome treated with melphalan high-dose therapy and autologous blood stem cell transplantation: a single-institution experience Annals of Hematology, May 10, 2012

10 Side effects in melanoma patients receiving adjuvant interferon alfa-2b therapy: a nurses perspective Supportive Care in Cancer, May 9, 2012

11 IMRT and carbon ion boost for malignant salivary gland tumors: interim analysis of the COSMIC trial Full Text BMC Cancer, May 8, 2012

12 Correlation of bevacizumab-induced hypertension and outcome in the BOXER study, a phase II study of capecitabine, oxaliplatin (CAPOX) plus bevacizumab as peri-operative treatment in 45 patients with poor-risk colorectal liver-only metastases unsuitable for upfront resection British Journal of Cancer, May 7, 2012

13 Skeletal muscle anabolism is a side effect of therapy with the MEK inhibitor: selumetinib in patients with cholangiocarcinoma British Journal of Cancer, May 7, 2012

14 Sunitinib-induced hyperparathyroidism Cancer, May 3, 2012    Clinical Article

15 Long term renal toxicity of ifosfamide in adult patients - 5year data European Journal of Cancer, April 30, 2012    Clinical Article

16 Polymorphic markers associated with severe oxaliplatin-induced, chronic peripheral neuropathy in colon cancer patients Cancer, April 24, 2012    Clinical Article

17 Pretherapeutic uracil and dihydrouracil levels of colorectal cancer patients are associated with sex and toxic side effects during adjuvant 5-flurorouracil-based chemotherapy Cancer, April 20, 2012    Clinical Article

18 Phase II study of gefitinib adaptive dose escalation to skin toxicity in recurrent or metastatic squamous cell carcinoma of the head and neck Oral Oncology , April 20, 2012    Clinical Article

19 Prevention of Pegfilgrastim-Induced Bone Pain Journal of Clinical Oncology, April 19, 2012    Clinical Article

20 Comparison of adverse events during 5-fluorouracil versus 5-fluorouracil/oxaliplatin adjuvant chemotherapy for stage III colon cancer Cancer, April 16, 2012    Clinical Article

Stereotactic ablative radiotherapy for stage I NSCLC: Recent advances and controversies Journal of Thoracic Disease, 08/05/2011

1 Comparison of adverse events during 5-fluorouracil versus 5-fluorouracil/oxaliplatin adjuvant chemotherapy for stage III colon cancer Cancer, April 16, 2012

2 Randomized phase III clinical trial of a combined treatment with carnitine + celecoxib ± megestrol acetate for patients with cancer-related anorexia/cachexia syndrome Clinical Nutrition, April 13, 2012

3 Extravasation of Liposomal Doxorubicin Induces Irritant Reaction without Vesicant Injury Anticancer Research, April 11, 2012

4 Prevention of Pegfilgrastim-Induced Bone Pain Journal of Clinical Oncology, April 19, 2012

5 The effect of guideline-consistent antiemetic therapy on chemotherapy-induced nausea and vomiting (CINV) Annals of Oncology, March 23, 2012

6 Cardiovascular status of childhood cancer survivors exposed and unexposed to cardiotoxic therapy Journal of Clinical Oncology, March 16, 2012

7 Long term renal toxicity of ifosfamide in adult patients - 5year data European Journal of Cancer, April 30, 2012

8 Reasons for avoidance of bevacizumab with first-line FOLFOX for advanced colorectal cancer International Journal of Clinical Oncology, March 20, 2012

9 Impact of oxaliplatin-induced neuropathy: a patient perspective Supportive Care in Cancer, March 20, 2012

10 Risk of serious toxicity in 1181 patients treated in phase I clinical trials of predominantly targeted anticancer drugs Annals of Oncology, March 2, 2012

11 Late effects of chemotherapy and radiotherapy in osteosarcoma and Ewing sarcoma patients Cancer, March 15, 2012

12 Polymorphic markers associated with severe oxaliplatin-induced, chronic peripheral neuropathy in colon cancer patients Cancer, April 24, 2012

13 Correlation of treatment-emergent adverse events and clinical response to endocrine therapy in early breast cancer Annals of Oncology, April 3, 2012

14 Plasma Diamine Oxidase Activity Is a Useful Biomarker for Evaluating Gastrointestinal Tract Toxicities during Chemotherapy with Oral Fluorouracil Anti-Cancer Drugs in Patients with Gastric Cancer Oncology (Karger), March 15, 2012

15 Incidence of thyroid hormone therapy in patients treated with sunitinib or sorafenib: A cohort study European Journal of Cancer, March 6, 2012

16 Ixabepilone-associated peripheral neuropathy Supportive Care in Cancer, March 5, 2012